A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...
Shingrix is a onetime vaccination, given in two doses a few months apart. The CDC recommends it starting at age 50 for most ...
Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
Two social engagement programs for people with early-stage dementia and their care partners will be available this April. The ...
Age-related brain diseases such as stroke, dementia, and late-life depression are a debilitating part of growing older, but people can lower their risk of these diseases through behavioral and ...
The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...
With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...
While Alzheimer’s disease is typically marked by a slow decline in memory and cognitive ability over a number of years, a ...
The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...
BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.